White v. Vertex Pharmaceuticals

CourtDistrict Court, E.D. Missouri
DecidedJuly 13, 2020
Docket1:20-cv-00059
StatusUnknown

This text of White v. Vertex Pharmaceuticals (White v. Vertex Pharmaceuticals) is published on Counsel Stack Legal Research, covering District Court, E.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
White v. Vertex Pharmaceuticals, (E.D. Mo. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI SOUTHEASTERN DIVISION MARY L. WHITE, . ) Plaintiff, Vv. Case No. 1:20-cv-59-SNLJ VERTEX PHARMACEUTICALS, Defendant. MEMORANDUM AND ORDER This matter is before the Court on the motion of self-represented plaintiff Mary L. White for leave to commence this civil action without payment of the required filing fee. (ECF No. 2). Having reviewed the financial information provided on plaintiff's Application to Proceed in District Court without Prepaying Fees or Costs, the Court finds the motion should be granted. Additionally, for the reasons explained below, the Court will allow plaintiff the opportunity to submit an amended complaint. Legal Standard Under 28 U.S.C. § 1915(e), the Court is required to dismiss a complaint filed in forma pauperis if it is frivolous, malicious, or fails to state a claim upon which relief can be granted, or seeks monetary relief against a defendant who is immune from such relief. To state a claim for relief, a complaint must plead more than “legal conclusions” and “[t]hreadbare recitals of the elements of a cause of action [that are] supported by mere conclusory statements.” Ashcroft v. Igbal, 556 U.S. 662, 678 (2009). A plaintiff must demonstrate a plausible claim for relief, which is more than a “mere possibility of misconduct.” Jd. at 679. “A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the

defendant is liable for the misconduct alleged.” Jd. at 678. Determining whether a complaint states a plausible claim for relief is a context-specific task that requires the reviewing court to draw on its judicial experience and common sense. Jd. at 679. When reviewing complaint filed by a self-represented person under 28 U.S.C. § 1915, the Court accepts the well-pled facts as true, White v. Clark, 750 F.2d 721, 722 (8th Cir. 1984), and liberally construes the complaint. Erickson v. Pardus, 551 U.S. 89, 94 (2007); Haines v. Kerner, 404 U.S. 519, 520 (1972). A “liberal construction” means that if the essence of an allegation is discernible, the district court should construe the plaintiffs complaint in a way that permits his or her claim to be considered within the proper legal framework. Solomon v. Petray, 795 F.3d 777, 787 (8th Cir. 2015). However, even self-represented complainants are required to allege facts which, if true, state a claim for relief as a matter of law. Martin v. Aubuchon, 623 F.2d 1282, 1286 (8th Cir. 1980). See also Stone v. Harry, 364 F.3d 912, 914-15 (8th Cir. 2004) (refusing to supply additional facts or to construct a legal theory for the self-represented plaintiff that assumed facts that had not been pleaded). The Complaint On March 20, 2020, self-represented plaintiff Mary L. White filed this civil suit on a Court- provided form against defendant Vertex Pharmaceuticals (“Vertex”).! Plaintiff alleges that in 2012 she was prescribed a “triple therapy” medication regimen which included “Incivek, Peginterferon alfa, and ribavirin combination” for treatment of her Hepatitis C. (ECF No. 1 at 5). Plaintiff states

1 On February 20, 2020, plaintiff filed two separate complaints against Dr. Eduardo D. Verzola and Genentech-Roche Pharmaceutical, respectively. See White v. Verzola, 4:20-cv-295-RLW (E.D. Mo.); White v. Genentech-Roche Pharmaceutical, 1:20-cv-41-RLW (E.D. Mo.). These two pending cases share similar facts and allegations with the instant action.

that the medication caused a “serious skin reaction that covered the entire body, mental stress, fatigue, anxiety, [and] loss of memory.” (/d.) Plaintiff alleges that the “manufacturer failed to warn the public of the dangerous side effect[s].” (d.) For relief, plaintiff requests the Court to award her $2 million in actual damages; $1.5 million for mental stress, anxiety, and loss of memory; $500,000 for loss of employment; and “all medical bills to be paid for the rest of [her] life.” (Ud at 5-6). Plaintiff also asks the Court to compensate an unknown individual, James R. Ward, $500,000 for “his lost will.” Discussion In the section of the form complaint to list specific federal statutes or constitutional provisions that the instant action is based upon, plaintiff wrote: “Bill of Rights.” Even construed liberally in favor of the self-represented plaintiff, her vague reference to the Bill of Rights is insufficient to construct a proper legal theory or to support the assertion that federal question jurisdiction exists in this case pursuant to 28 U.S.C. § 1331. See Stone, 364 F.3d at 914-15 (refusing to construct a legal theory for a self-represented plaintiff); Gwaltney v. White, 2016 WL 3255029, at *2 (M.D.N.C. June 13, 2016) (asserting a claim under the “Bill of Rights” does not sufficiently allege federal question jurisdiction under 28 U.S.C. § 1331). In liberally construing the complaint, the Court interprets her allegations to assert a claim for product liability/failure to warn against Vertex. For the purpose of conducting a pre-service review of the complaint pursuant to 28 U.S.C. § 1915, the Court will presume it has diversity jurisdiction over the instant action as she has asserted an amount in controversy that exceeds the jurisdictional threshold and has established the diversity of the parties. See 28 U.S.C. § 1332(a); Ryan ex rel. Ryan v. Schneider Nat. Carriers, Inc., 263 F.3d 816, 819 (8th Cir. 2001) (“district

courts have original diversity jurisdiction over civil actions when the matter in controversy exceeds $75,000 . . . and when the citizenship of each plaintiff is different from the citizenship of each defendant”). Here, plaintiff seeks $2,000,000 in actual damages and states that she is a Missouri, citizen and Vertex’s principal place of business is in Massachusetts. See 28 U.S.C. § 1332(c)(1) (generally, a corporation is deemed to be a citizen “of the State by which it has been incorporated and of the State where it has its principal place of business.”). However, the Court finds that plaintiff has failed to allege facts permitting the reasonable inference that defendant Vertex is liable for any misconduct. Although plaintiff generally states that Vertex is a manufacturer in the section of the complaint designated to list the parties, she fails to allege that Vertex manufactured the three-drug combination that she was prescribed. While well-pled factual allegations are taken as true, the Court is free to ignore unsupported conclusions and inferences. See Wiles v. Capitol Indem.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hanna v. Plumer
380 U.S. 460 (Supreme Court, 1965)
Haines v. Kerner
404 U.S. 519 (Supreme Court, 1972)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Kevin Ward v. Bradley Smith
721 F.3d 940 (Eighth Circuit, 2013)
Great Plains Trust Co. v. Union Pacific Railroad
492 F.3d 986 (Eighth Circuit, 2007)
Johnson v. Medtronic, Inc.
365 S.W.3d 226 (Missouri Court of Appeals, 2012)
James Solomon v. Deputy U.S. Marshal Thomas
795 F.3d 777 (Eighth Circuit, 2015)
Danny Lockett v. United States
333 F. App'x 143 (Eighth Circuit, 2009)
Mark Neubauer v. FedEx Corporation
849 F.3d 400 (Eighth Circuit, 2017)
Patric Patterson v. Kennie Bolden
902 F.3d 845 (Eighth Circuit, 2018)
Martin v. Aubuchon
623 F.2d 1282 (Eighth Circuit, 1980)

Cite This Page — Counsel Stack

Bluebook (online)
White v. Vertex Pharmaceuticals, Counsel Stack Legal Research, https://law.counselstack.com/opinion/white-v-vertex-pharmaceuticals-moed-2020.